4591 — Ribomic Income Statement
0.000.00%
Last trade - 00:00- ¥4bn
- ¥998m
Annual income statement for Ribomic, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 121 | 92 | 80.9 | 66 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,036 | 1,333 | 1,877 | 1,854 | 1,156 |
| Operating Profit | -915 | -1,241 | -1,796 | -1,789 | -1,156 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -854 | -1,186 | -1,684 | -1,652 | -1,023 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -855 | -1,187 | -1,685 | -1,653 | -1,024 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -855 | -1,187 | -1,685 | -1,653 | -1,024 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -855 | -1,187 | -1,685 | -1,653 | -1,024 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -53.6 | -46.1 | -58.8 | -53.1 | -28 |
| Dividends per Share |